Yuvraj_pawp, Author at Pharma Advancement

ORIC Pharmaceuticals, a privately held oncology company focused on the discovery and development of drugs to address treatment resistant cancers,...

Rgenix Reports Phase 1a/B Clinical Data Demonstrating Immune-Stimulatory Activity With RGX-104

by Yuvraj_pawp

31st October 2017

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today preliminary data from...

Bayer leads the way in modern development standards for evidence-based phytomedicine with Iberogast

by Yuvraj_pawp

30th October 2017

As consumer demand for herbal medicine continues to grow, the healthcare industry is under increasing pressure to demonstrate how plant-based...

Boehringer Ingelheim achieves major breakthrough in canine cardiology

by Yuvraj_pawp

30th October 2017

Dogs suffering from cardiovascular disease and related clinical signs will officially have an opportunity for a better and longer life,...

Astellas Partners with CNBC for its Global Branding Campaign

by Yuvraj_pawp

30th October 2017

Astellas Pharma Inc. announced the next installment of its global corporate branding initiative, which it is conducting in collaboration with...

Allergan Receives Approval for Ozurdex in China for the Treatment of Retinal Vein Occlusion (RVO)

by Yuvraj_pawp

30th October 2017

Allergan plc announced that it has received an Imported Drugs License (IDL) from the Chinese FDA to market Ozurdex® (dexamethasone...

Meta-Analysis Using Real-World Data Evaluates Safety Profile of Entyvio® (vedolizumab) in Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

by Yuvraj_pawp

30th October 2017

Takeda Pharmaceutical Company Limited announced the presentation of real-world evidence from two analyses evaluating the safety profile of Entyvio® (vedolizumab),...

ViiV Healthcare announces positive results from phase III BRIGHTE study of fostemsavir in HTE patients with HIV-1 infection

by Yuvraj_pawp

30th October 2017

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced results...

Biohaven announces first patient treated in clinical research collaboration at Rutgers Cancer Institute

by Yuvraj_pawp

30th October 2017

Biohaven Pharmaceutical Holding Company, a clinical-stage biopharmaceutical company, announced a clinical collaboration with Drs. Ann Silk and James Goydos at...

Biogen And Eisai Expand Existing Collaboration Agreement To Develop And Commercialize Investigational for Alzheimer’s Disease Treatments

by Yuvraj_pawp

30th October 2017

Eisai Co., Ltd. and Biogen Inc. announced that the companies have expanded their existing agreement to jointly develop and commercialize...

New Method of Drug Value: Incorporating Real-World Data

AI And The Future of Drug Discovery And Manufacturing

AI Technology Transforming Pharmaceutical Route Scouting

Advancing Biologics : New Drug Delivery Methods In Focus

Nanoparticles : Next Frontier In Pharmaceutical Innovations

Nickel Complex Innovations Streamlines Drug Development

Streamlining Toxicology Materials For IND And FIH Studies

Booming Radiopharmaceuticals Industry Attracts Investors

FDA Grants Breakthrough Status To GSKs Lung Cancer Drug

New Method of Drug Value: Incorporating Real-World Data

AI And The Future of Drug Discovery And Manufacturing

AI Technology Transforming Pharmaceutical Route Scouting

Advancing Biologics : New Drug Delivery Methods In Focus

Nanoparticles : Next Frontier In Pharmaceutical Innovations

Nickel Complex Innovations Streamlines Drug Development

Streamlining Toxicology Materials For IND And FIH Studies

Booming Radiopharmaceuticals Industry Attracts Investors

FDA Grants Breakthrough Status To GSKs Lung Cancer Drug

Yuvraj_pawp

ORIC Pharma begins phase 1 study of novel GR antagonist with planned development for oncology

Rgenix Reports Phase 1a/B Clinical Data Demonstrating Immune-Stimulatory Activity With RGX-104

Bayer leads the way in modern development standards for evidence-based phytomedicine with Iberogast

Boehringer Ingelheim achieves major breakthrough in canine cardiology

Astellas Partners with CNBC for its Global Branding Campaign

Allergan Receives Approval for Ozurdex in China for the Treatment of Retinal Vein Occlusion (RVO)

Meta-Analysis Using Real-World Data Evaluates Safety Profile of Entyvio® (vedolizumab) in Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

ViiV Healthcare announces positive results from phase III BRIGHTE study of fostemsavir in HTE patients with HIV-1 infection

Biohaven announces first patient treated in clinical research collaboration at Rutgers Cancer Institute

Biogen And Eisai Expand Existing Collaboration Agreement To Develop And Commercialize Investigational for Alzheimer’s Disease Treatments

Qucik Links

About Us

System

Resources

Retrieve your password